Mats Ljungman, Ph.D., presents talk on breakthrough KLIPP precision cancer-targeting technique at AACR annual meeting

University of Michigan Center for RNA Biomedicine Co-Director Dr. Mats Ljungman presented research on his KLIPP technique at the American Association for Cancer Research (AACR) Annual Meeting at the San Diego Convention Center in California.

Dr. Ljungman’s talk, “KLIPP: Precision targeting of cancer with CRISPR,” was given on Tuesday, April 9, as part of the session, Novel Approaches for Targeted Therapies, a two-hour “minisymposium” where leading cancer researchers presented their latest discoveries in clinical research.

Dr. Ljungman, a Rogel Cancer Center researcher and professor in U-M Radiation Oncology, was recently awarded a $3.7 million grant from the National Institutes of Health (NIH) for the purpose of continuing his groundbreaking work with precision-targeting KLIPP cancer therapy – the project’s highest funding by far to date.

Michigan Medicine correspondent Anna Megdell was on hand to cover the event, which also featured talks by several center faculty members including Arul Chinnaiyan, M.D., Ph.D., Sunitha Nagrath, Ph.D., Maria Castro, Ph.D., and Amanda Garner, Ph.D., and poster presentations given by several lab members. See a complete list of presentations here.

Read Anna’s full story, and follow the official hashtag #AACR24 to get the latest news from the most important cancer meeting in the world. Congratulations Mats!

Similar Posts